WordNet

a normal ongoing process that dissolves fibrin and results in the removal of small blood clots; "drugs causing fibrinolysis have been utilized therapeutically"

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 急性肺塞栓症患者の血栓溶解療法へのアプローチ：患者の選択と管理approach to thrombolytic fibrinolytic therapy in acute pulmonary embolism patient selection and administration [show details]
… catheter-directed thrombolytic therapy (CDT), may also be confirmatory . Occasionally, thrombolytic therapy is administered when a diagnosis is made with bedside echocardiography. Thrombolytic therapy can be administered …
2. 急性虚血性脳卒中へのアルテプラーゼ静注療法：治療的使用intravenous thrombolytic therapy for acute ischemic stroke therapeutic use [show details]
…The sooner intravenous alteplase treatment is initiated after ischemic stroke, the more likely it is to be beneficial. The benefits and risks of thrombolytic therapy with alteplase are discussed in detail …
3. 急性ST上昇型心筋梗塞：血栓溶解療法の実施acute st elevation myocardial infarction the use of fibrinolytic therapy [show details]
… fibrin-specific agent instead of streptokinase . We suggest tenecteplase or reteplase instead of alteplase . Dosing is available in a table Early transfer to a PCI center after fibrinolysis should be recommended …
4. 急性虚血性脳卒中への再灌流療法approach to reperfusion therapy for acute ischemic stroke [show details]
… the benefit of alteplase is time dependent, it is critical to treat patients as quickly as possible. Alteplase, a recombinant tissue plasminogen activator (tPA), initiates local fibrinolysis by binding to …
5. 急性下肢虚血の管理のための動脈内血栓溶解療法intra arterial thrombolytic therapy for the management of acute limb ischemia [show details]
… degrades the fibrin blood clot . Several thrombolytic agents are available, including the first-generation plasminogen activators, streptokinase and urokinase, second-generation plasminogen activators …

Japanese Journal

対談血液および血液疾患を語る(7)線維素溶解現象の解明

青木延雄,齋藤英彦
最新医学 64(10), 2305-2312, 2009-10
NAID 40016847298

治療の進歩線溶療法

新谷憲治
日本内科学会雑誌 86(6), 972-980, 1997-06-10
… 線溶療法は,線維素溶解現象を利用して速やかに血管内に形成された血栓を取り除き,虚血性障害をできるだけ少なくする目的で行われる.リコンビナントのプラスミノゲンアクチベータ(PA)製剤が開発され,急性心筋梗塞症をはじめとする多くの血栓性疾患でその臨床的有用性が認められつつある.発症後治療が開始されるまでの時間が血栓溶解療法の成否を決定する.フィブリン特異的PA活性を示すt-PA製剤を用いても,完全な …
NAID 10005231055